Prof. Dr. Thomas Illig participates in RESIST research project A2.
| My Research Interest in RESIST |
Our research focus in RESIST is the identification of structural and other genetic variants in persons with severe immune deficiencies. We work closely together with the clinics and institutes of Prof. Grimbacher (Freiburg) and Prof. Schmidt (MHH). Moreover the Hannover Unified Biobank (HUB) is deeply involved in establishing a control population of healthy elderly individuals as well as diseased cohorts for different viral infections in close cooperation with the MHH clinics of Dermatology (Prof. Werfel), Neurology (Prof. Stangel) and Rheumatology (Prof. Witte).
Prof. Illig and his team
Prof. Dr. Thomas Illig – Curriculum Vitae
Current Position
Undergraduate and Postgraduate Training
Academic and Research Posts
Other Scientific Roles
Awards and Prizes
10 Selected Publications (of > 177 original publications)
Penkert J, Ripperger T, Schieck M, Schlegelberger B, Steinemann D, Illig T. On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer. Oncotarget. 2016; 7(41): 67626-49.
Fuchsberger C, Flannick J, Teslovich TM, … Ingelsson E, Im HK, Illig T, … Boehnke M, Altshuler D, McCarthy MI. The genetic architecture of type 2 diabetes. Nature. 2016; 536(7614):41-7.
Wang-Sattler R, Yu Z, Herder C, … Pischon T, Adamski J, Illig T. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol. 2012; 8: 615.
Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, Prehn C, Roemisch-Margl W, Polonikov A, Peters A, Theis FJ, Meitinger T, Kronenberg F, Weidinger S, Wichmann HE, Suhre K, Wang-Sattler R, Adamski J, Illig T. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet. 2011; 7(8): e1002215.
Suhre K, Wallaschofski H, Raffler J, Friedrich N, Haring R, Michael K, Wasner C, Krebs A, Kronenberg F, Chang D, Meisinger C, Wichmann HE, Hoffmann W, Völzke H, Völker U, Teumer A, Biffar R, Kocher T, Felix SB, Illig T, Kroemer HK, Gieger C, Römisch-Margl W, Nauck M. A genome-wide association study of metabolic traits in human urine. Nat Genet. 2011; 43(6): 565-9.
Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wägele B, Altmaier E; CARDIoGRAM, Deloukas P, Erdmann J, Grundberg E, Hammond CJ, de Angelis MH, Kastenmüller G, Köttgen A, Kronenberg F, Mangino M, Meisinger C, Meitinger T, Mewes HW, Milburn MV, Prehn C, Raffler J, Ried JS, Römisch-Margl W, Samani NJ, Small KS, Wichmann HE, Zhai G, Illig T, Spector TD, Adamski J, Soranzo N, Gieger C. Human metabolic individuality in biomedical and pharmaceutical research. Nature. 2011; 477(7362): 54-60
Illig T, Gieger C, Zhai G, Römisch-Margl W, Wang-Sattler R, Prehn C, Altmaier E, Kastenmüller G, Kato BS, Mewes HW, Meitinger T, de Angelis MH,Kronenberg F, Soranzo N, Wichmann HE, Spector TD, Adamski J, Suhre K. A genome-wide perspective of genetic variation in human metabolism. Nat Genet. 2010; 42(2): 137-41.
Kretzschmar H, Illig T. Are further genetic factors associated with the risk of developing variant Creutzfeldt- Jakob disease? Lancet Neurol. 2009; 8(1): 25-6. No abstract available.
Weidinger S, Gieger C, Rodriguez E, Baurecht H, Mempel M, Klopp N, Gohlke H, Wagenpfeil S, Ollert M, Ring J, Behrendt H, Heinrich J, Novak N, Bieber T, Krämer U, Berdel D, von Berg A, Bauer CP, Herbarth O, Koletzko S, Prokisch H, Mehta D, Meitinger T, Depner M, von Mutius E, Liang L, Moffatt M, Cookson W, Kabesch M, Wichmann HE, Illig T. Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS Genet. 2008; 4(8): e1000166.
Laumen H, Saningong AD, Heid IM, Hess J, Herder C, Claussnitzer M, Baumert J, Lamina C, Rathmann W, Sedlmeier EM, Klopp N, Thorand B, Wichmann HE, Illig T*, Hauner H*.Functional characterisation of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes. 2009; 58(4): 984-91.
